Provided by Tiger Trade Technology Pte. Ltd.

ANI Pharmaceuticals

74.22
-1.1300-1.50%
Volume:149.82K
Turnover:11.18M
Market Cap:1.70B
PE:16.35
High:75.81
Open:75.31
Low:74.16
Close:75.35
52wk High:99.50
52wk Low:70.15
Shares:22.97M
Float Shares:20.28M
Volume Ratio:0.54
T/O Rate:0.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.54
EPS(LYR):3.32
ROE:20.46%
ROA:5.45%
PB:2.85
PE(LYR):22.36

Loading ...

Emmaus Life Sciences Q1 FY26 net loss widens to $3.3 million; net revenues fall 18% to $2 million

Reuters
·
May 16

Top Executives Quietly Unload a Wave of ANI Pharmaceuticals Shares

TIPRANKS
·
May 14

ANI Pharma director Patrick D. Walsh disposes common shares worth $1.13 million

Reuters
·
May 14

ANI Pharma CEO Nikhil Lalwani sells 55,000 shares for $4.27 million

Reuters
·
May 14

ANI SVP Thomas Rowland disposes 459 shares for $36,357.39

Reuters
·
May 14

ANI Pharma General Counsel Meredith Cook sells 500 shares worth $39,080

Reuters
·
May 14

ANI Pharma releases corporate presentation outlining rare-disease shift, 2026 revenue outlook $1.1-$1.14 billion

Reuters
·
May 13

Analysts Offer Insights on Healthcare Companies: ANI Pharmaceuticals (ANIP), Definitive Healthcare Corp (DH) and Denali Therapeutics (DNLI)

TIPRANKS
·
May 11

Guggenheim Sticks to Its Buy Rating for ANI Pharmaceuticals (ANIP)

TIPRANKS
·
May 11

U.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla

Reuters
·
May 11

ANI Pharmaceuticals Inc : Piper Sandler Cuts Target Price to $105 From $111

THOMSON REUTERS
·
May 11

ANI Pharmaceuticals (ANIP) Profit Swing And One Off Gain Test Bullish Narratives

Simply Wall St.
·
May 09

H.C. Wainwright Sticks to Their Buy Rating for ANI Pharmaceuticals (ANIP)

TIPRANKS
·
May 09

ANI Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Sector Update: Healthcare Stocks Steady Pre-Bell Friday

MT Newswires Live
·
May 08

Update: ANI Pharmaceuticals Q1 Adjusted Earnings, Revenue Rise; Lifts 2026 Outlook

MT Newswires Live
·
May 08

GUIDANCE: (ANIP) ANI Pharmaceuticals Expects 2026 Adjusted EPS Range $9.19 to $9.69, vs. FactSet Est of $9.07

MT Newswires Live
·
May 08

Stock Track | ANI Pharmaceuticals Soars 5.35% in Pre-market on Strong Earnings Beat, Raised Guidance and $100M Buyback

Stock Track
·
May 08

ANI Pharma Q1 FY26 net income rises 93.1% to USD 29.5 million; revenue increases 20.5% to USD 237.5 million

Reuters
·
May 08

BRIEF-ANI Pharmaceuticals Q1 Adjusted EPS USD 2.05 Vs. IBES Estimate USD 1.3

Reuters
·
May 08